참고문헌
- Adibi M, Karam JA, Wood CG (2015). Reporting geographic and temporal trends in renal cell carcinoma: why is this important? Eur Urol, 67, 531-2. https://doi.org/10.1016/j.eururo.2014.10.030
- Belldegrun AS (2007). Renal Cell Carcinoma: Prognostic Factors and Patient Selection. European Urology Supplements, 6, 477-83. https://doi.org/10.1016/j.eursup.2007.01.016
- Choueiri TK, Rini B, Garcia JA, et al (2007). Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma. Ann Oncol, 18, 249-55.
- Cohen HT, McGovern FJ (2005). Renal-cell carcinoma. N Engl J Med, 353, 2477-90. https://doi.org/10.1056/NEJMra043172
- Cross BW, Johnson TV, DeRosa AB, et al (2012). Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy. Int J Surgical Oncol, 6.
- Ficarra V, Galfano A, Verhoest G, et al (2007). Prognostic Factors and Staging Systems for Renal Cell Carcinoma. European Urol Supplements, 6, 623-9. https://doi.org/10.1016/j.eursup.2007.03.008
- Furniss D, Harnden P, Ali N, et al (2008). Prognostic factors for renal cell carcinoma. Cancer Treat Rev, 34, 407-26. https://doi.org/10.1016/j.ctrv.2007.12.008
- Guethmundsson E, Hellborg H, Lundstam S, et al (2011). Metastatic potential in renal cell carcinomas =7 cm: Swedish Kidney Cancer Quality Register data. Eur Urol, 60, 975-82. https://doi.org/10.1016/j.eururo.2011.06.029
- Hutterer GC, Patard JJ, Perrotte P, et al (2007). Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram. Int J Cancer, 121, 2556-61. https://doi.org/10.1002/ijc.23010
- Karakiewicz PI, Trinh QD, Bhojani N, et al (2007). Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol, 51, 1616-24. https://doi.org/10.1016/j.eururo.2006.12.015
- Lam JS, Shvarts O, Leppert JT, et al (2005). Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol, 173, 1853-62. https://doi.org/10.1097/01.ju.0000165693.68449.c3
- Leibovich BC, Blute ML, Cheville JC, et al (2003). Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer, 97, 1663-71. https://doi.org/10.1002/cncr.11234
- Ljungberg B, Bensalah K, Canfield S, et al (2015). EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol, 67, 913-24. https://doi.org/10.1016/j.eururo.2015.01.005
- Ljungberg B, Campbell SC, Choi HY, et al (2011). The epidemiology of renal cell carcinoma. Eur Urol, 60, 615-21. https://doi.org/10.1016/j.eururo.2011.06.049
- Masuda H, Kurita Y, Suzuki K, et al (1997). Predictive value of serum immunosuppressive acidic protein for staging renal cell carcinoma: comparison with other tumour markers. Br J Urol, 80, 25-9. https://doi.org/10.1046/j.1464-410X.1997.00244.x
- Miyata Y, Koga S, Nishikido M, et al (2001). Relationship between serum ferritin levels and tumour status in patients with renal cell carcinoma. BJU Int, 88, 974-7.
- Motzer RJ, Bacik J, Mazumdar M (2004). Prognostic factors for survival of patients with stage IV renal cell carcinoma: Memorial Sloan-Kettering Cancer Center experience. Clin Cancer Res, 10, 6302-3. https://doi.org/10.1158/1078-0432.CCR-040031
- Motzer RJ, Mazumdar M, Bacik J, et al (1999). Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol, 17, 2530-40. https://doi.org/10.1200/JCO.1999.17.8.2530
- Naito S, Kinoshita H, Kondo T, et al (2013). Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: a multicenter study of 556 patients. Urol, 82, 846-51. https://doi.org/10.1016/j.urology.2013.06.035
- Procopio G, Verzoni E, Iacovelli R, et al (2012). Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies. Br J Cancer, 107, 1227-32. https://doi.org/10.1038/bjc.2012.327
- Rampersaud EN, Klatte T, Bass G, et al (2014). The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma. Urol Oncol, 32, 9-13.
- Sengupta S, Lohse CM, Cheville JC, et al (2006). The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer, 106, 304-12. https://doi.org/10.1002/cncr.21617
- Sidharth, Luitel BR, Gupta DK, et al (2011). Pattern of renal cell carcinoma - a single center experience in Nepal. Kathmandu Univ Med J (KUMJ), 9, 185-8.
- Toyoda Y, Shinohara N, Harabayashi T, et al (2007). Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol, 52, 163-8. https://doi.org/10.1016/j.eururo.2006.10.060
- Umbas R, Safriadi F, Mochtar CA, et al (2015). Urologic cancer in Indonesia. Jpn J Clin Oncol, 45, 708-12. https://doi.org/10.1093/jjco/hyv066
- Yap NY, Ng KL, Ong TA, et al (2013). Clinical prognostic factors and survival outcome in renal cell carcinoma patients--a Malaysian single centre perspective. Asian Pac J Cancer Prev, 14, 7497-500. https://doi.org/10.7314/APJCP.2013.14.12.7497
- Znaor A, Lortet-Tieulent J, Laversanne M, et al (2015). International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol, 67, 519-30. https://doi.org/10.1016/j.eururo.2014.10.002